000			02124cam a2200349 4500500
005			20250112060326.0
041			_afre
042			_adc
100	1	0	_aBenali, Ilham _eauthor
700	1	0	_a Acha, Nawfal _eauthor
700	1	0	_a Barka, Hafid _eauthor
245	0	0	_aDeterminants of pharmaceutical innovation in low- and middle-income countries: Empirical study conducted in Morocco
260			_c2021.
500			_a27
520			_aAs pharmaceutical firms in low- and middle-income countries (LMICs) face difficulties related to research and development (R&D) costs, regulation, competition from imported drugs, and patent expiry, innovation is becoming their main means of survival and evolution. Yet research that examines innovation in a context similar to ours is rare. We have conducted the present research to remedy this shortcoming and to provide managers with tools that enable them to generate innovation in their companies. The main interest of this paper is to present the different dimensions of pharmaceutical innovation and to identify the main factors that promote it. Through a logistic regression model, we show that R&D activities, internal work organization, and export are the main drivers of product and process innovation. Moreover, the age and size of the firm do not significantly influence these two types of innovation.
690			_alow- and middle-income countries
690			_apharmaceutical innovation
690			_alicensed manufacturing
690			_alogistic regression
690			_aorganizational structure
690			_aresearch and development
690			_apartnership agreements
690			_apharmaceutical innovation
690			_alicensed manufacturing
690			_alow and middle-income countries
690			_alogistic regression
690			_aorganizational structure
690			_aresearch and development
690			_apartnership agreements
786	0		_nRevue Management & Innovation | o 3 | 1 | 2021-03-29 | p. 137-156 | 2658-9222
856	4	1	_uhttps://shs.cairn.info/journal-revue-management-et-innovation-2021-1-page-137?lang=en
999			_c222183 _d222183